Rational design synthesis and biological evaluation of simplified taccalonolide analogs for the treatment of cancer

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Frantz Douglas

Funded by

Cancer Prevention and Res Inst of TX 527

Research Start Date

03/01/2023

Status

Active

Basic Research

Collaborative Project

Basic Research

Drug Discovery

Cancer

Bioscience Research Panel